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ABSTRACT Sialic acids (Sias) are important glycans displayed on the cells and tis-
sues of many different animals and are frequent targets for binding and modifica-
tion by pathogens, including influenza viruses. Influenza virus hemagglutinins bind
Sias during the infection of their normal hosts, while the encoded neuraminidases
and/or esterases remove or modify the Sia to allow virion release or to prevent re-
binding. Sias naturally occur in a variety of modified forms, and modified Sias can al-
ter influenza virus host tropisms through their altered interactions with the viral gly-
coproteins. However, the distribution of modified Sia forms and their effects on
pathogen-host interactions are still poorly understood. Here we used probes devel-
oped from viral Sia-binding proteins to detect O-acetylated (4-O-acetyl, 9-O-acetyl,
and 7,9-O-acetyl) Sias displayed on the tissues of some natural or experimental hosts
for influenza viruses. These modified Sias showed highly variable displays between
the hosts and tissues examined. The 9-O-acetyl (and 7,9-) modified Sia forms were
found on cells and tissues of many hosts, including mice, humans, ferrets, guinea
pigs, pigs, horses, dogs, as well as in those of ducks and embryonated chicken egg
tissues and membranes, although in variable amounts. The 4-O-acetyl Sias were
found in the respiratory tissues of fewer animals, being primarily displayed in the
horse and guinea pig, but were not detected in humans or pigs. The results suggest
that these Sia variants may influence virus tropisms by altering and selecting their
cell interactions.
IMPORTANCE Sialic acids (Sias) are key glycans that control or modulate many nor-
mal cell and tissue functions while also interacting with a variety of pathogens, in-
cluding many different viruses. Sias are naturally displayed in a variety of different
forms, with modifications at several positions that can alter their functional interac-
tions with pathogens. In addition, Sias are often modified or removed by enzymes
such as host or pathogen esterases or sialidases (neuraminidases), and Sia modifica-
tions can alter those enzymatic activities to impact pathogen infections. Sia chemical
diversity in different hosts and tissues likely alters the pathogen-host interactions
and influences the outcome of infection. Here we explored the display of 4-O-acetyl,
9-O-acetyl, and 7,9-O-acetyl modified Sia forms in some target tissues for influenza
virus infection in mice, humans, birds, guinea pigs, ferrets, swine, horses, and dogs,
which encompass many natural and laboratory hosts of those viruses.
KEYWORDS host range, influenza, receptor-ligand interaction, respiratory viruses,
sialic acid, virus-host interactions
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All cells are decorated on their surfaces with a complex array of oligosaccharides(glycans) that are attached to membrane glycoproteins and glycolipids or which
make up the different components of soluble extracellular materials such as mucus and
which are involved in the initial interactions of viruses or other pathogens with cells or
mucosal surfaces (1). The chemical diversity of these glycans contributes to their
complex functional roles in controlling cell-cell, cell-pathogen, and cell-environment
interactions. Linear and branched glycoconjugates of vertebrate cells are often termi-
nated in sialic acids (Sias). Sias have critical roles in maintaining a variety of cell
functions due to their abundance as exposed terminal sugars, where they are involved
in highly specific and regulated cellular lectin interactions (2, 3). They have also been
exploited by many different pathogens as well as by nonpathogenic microbes for host
recognition and attachment, including playing a role as receptors for important
disease-causing viruses, bacteria, and parasites (4, 5).
Sias are nine-carbon -keto acids that may be produced and displayed in
multiple modified forms that differ in expression between organisms, tissues, and
even individual cells (1, 6, 7). In one series of modifications, the most common form,
N-acetylneuraminic acid (Neu5Ac), may be modified with acetyl groups (O-linked) at
carbons -4, -7, -8, and/or -9 (8, 9). The presence and levels of O-acetylation likely result
from combined functions of sialic acid O-acetyl transferases (SOAT) and esterases
(SOAE), some of which have been identified and functionally demonstrated, while
others are not yet characterized (10–12). A variety of studies have contributed to our
understanding of the relative abundances and distributions of O-acetylated Sias in
various eukaryotic systems, as reviewed by Mandal et al. (13). However, the recent
development of recombinant sialoglycan-recognizing probes (SGRPs) recognizing dif-
ferent O-acetylated Sia forms allows their display at the cellular and tissue levels to be
analyzed in more detail (14).
Sia-lectin interactions are critical within organisms, and O-acetyl modifications
modulate a variety of intrinsic host functions. Our understanding is clearest for the
9-O-acetyl-modified Sias, which have been detected in human and some other animal
tissues with influenza C virus hemagglutinin-esterase fusion (HEF) proteins (8) and
subsequently with porcine Torovirus HE (14). Those studies showed that 9-O-acetyl
(9-O-Ac) Sias were common in many human tissues and on many cell lines of human
origins, as well as being expressed by other animals and displayed within their tissues
with highly variable patterns. Removal of 9-O-Ac Sias by expression of the influenza C
9-O-acetylesterase in transgenic mice resulted in developmental arrest of embryos
around the 2-cell stage (15). Regulated 9-O-acetylation is also widely involved in various
immunological pathways. For example, modification of the ganglioside GD3 (CD60) of
proliferating T cells affects apoptotic pathways and their differentiation states (16),
while Sia 9-O-acetylation on B-cell surface glycans blocks recognition by Sia-binding
immunoglobulin-type lectin Siglec-2 (CD22), inhibiting receptor signaling and B-cell
activation (17). Given their involvement in and regulation of cell signaling and prolif-
eration processes, it is not surprising that abnormally displayed O-acetylated Sias are
often oncogenic markers (18–21). Further additions of O-acetyl groups to the 7 and 8
positions give rise to di- and tri-O-acetylated Sias, respectively.
The display and functions of modified 4-O-Ac Sias in intrinsic cell processes are
poorly understood. They have been previously identified using high-performance liquid
chromatography (HPLC) analyses in certain tissues, blood proteins, and erythrocytes
and within the cells of vertebrates of varied lineages, including horses and donkeys,
guinea pigs, mice, and monotremes, and in many lineages of bony fish (14, 22–26). They
appear to be distributed in fewer species than the O-acetyl modifications on the Sia
glycerol side chain.
Influenza virus particles are decorated with the major glycoproteins hemagglutinin
(HA) (displayed as trimers) and neuraminidase (NA) (displayed as tetramers) (27). Sias
act as functional receptors for influenza virus infection as they are recognized and
bound by the HA and are cleaved from cell glycans (and viral glycoproteins) by the
sialidase function of NA (28–30). The specific chemistry and linkages of the cell Sias
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have long been known to influence HA and NA specificity and, ultimately, influenza
virus infectivity. Influenza A virus (IAV) and influenza B virus (IBV) HAs from many hosts
show strong preferences for binding and infection using Neu5Ac as a receptor, while
modified Sias, including Neu5Gc and O-acetyl forms, may reduce or alter infection by
those viruses (31). The Sia sugar linkage to the penultimate residue (2-3 versus 2-6)
affects HA Sia binding affinity and also contributes to host tropism differences between
avian and human influenza virus strains (32, 33). O-acetyl modified Sias have been
reported to affect influenza virus infections by altering the activities of HA and NA. One
reported effect of O-acetylation is a general reduction in susceptibility to cleavage by
sialidases, including influenza virus NA (34). A number of inhibitors of influenza viruses
were identified historically, including the -inhibitors, which are defined as sugar
molecules that interact with influenza viruses to inhibit infection by acting as “decoy”
receptors (35–38). The 9-O-Ac Sias were also reported to reduce the sialidase activity of
NA by almost 3-fold (39). Strong inhibition of infection and cell-to-cell spread of some
human IAVs by horse and guinea pig sera was associated with the presence of high
levels of 4-O-Ac Sias on plasma glycoproteins, including -2-macroglobulin (35, 37,
40–43).
In other cases, the O-acetyl-modified Sias are required for cell infection by viruses.
Both influenza C viruses and influenza D viruses encode a HEF glycoprotein that binds
9-O-Ac Sias as a functional receptor and that also contains a 9-O-Ac-specific esterase
that promotes viral release from that Sia form (44, 45). The orthomyxovirus salmon
anemia virus and the coronavirus mouse hepatitis virus-S strain each use 4-O-Ac Sia as
a specific receptor for cell binding and infection and also express esterases that can
remove that modification (46, 47).
The modified Sia may also alter the cell and tissue interactions with other viruses, as
well as modifying infections of various bacteria and parasites. For example, reovirus
type 3 infection and replication were inhibited by the presence of 9-O-Ac Sia (48), as
was Plasmodium falciparum binding to and invasion of erythrocytes (49). Many bacte-
ria—both pathogens and commensals—bind to Sia and often express sialidases
(neuramindases) that cleave it from glycans, and those activities are likely susceptible
to the effects of modifications of the Sia substrate (50–53). In the bacterial oral
pathogen Tannerella forsythia, an acetylesterase (NanS) is encoded within the Sia
operon to remove human 9-O-Ac modifications and improve NanH sialidase function
(54). Understanding the differences in the display and cell or tissue distributions of
these modified Sia forms between various animals would therefore be of general
interest for understanding how they may alter animal susceptibility to pathogens.
Identifying their patterns of expression in tissues of hosts for influenza virus would also
help to clarify their roles in controlling HA and NA specificities and activities and hence
their effects on tropisms and host ranges of those viruses (55).
Here we used previously described recombinant soluble viral SGRPs or “virolectins”
(14) with specificities for different O-acetylated Sias, as well as esterases active against
the same modifications, to survey the diversity of these modified forms on the cells and
tissues that are targets for infection by influenza virus and other viruses in their natural
hosts, as well as in some animal models.
RESULTS
SGRPs identifying specific O-acetylated Sia moieties. We used the recombinant
soluble HE proteins from three nidoviruses as SGRPs to survey for the display of
O-acetylated modified Sias in the respiratory tract tissues that are the natural sites of
influenza virus infection in mammals, as well as in the gastrointestinal tract tissues in
Pekin duck (Anas platyrhynchos domesticus) and the tissues of embryonated chicken
eggs. These SGRPs have been previously characterized with defined Sia binding and
esterase activities (14). Mouse hepatitis virus S strain (MHV-S) HE recognizes 4-O-Ac Sia,
bovine coronavirus Mebus strain (BCoV-Mebus) HE primarily recognizes 7,9-O-Ac Sia,
and porcine Torovirus P4 strain (PToV-P4) HE recognizes 9-O-Ac Sia. Hosts examined
included those that are naturally infected and which sustain transmission of influenza
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viruses in nature (humans, Pekin ducks, swine, horses and dogs) and those used as
experimental models for human influenza virus infection and transmission (mice,
ferrets, and guinea pigs).
The HE proteins are fused to the Fc region of human IgG1 and to a hexahistidine
(His6) sequence, allowing ready expression, purification, and detection (Fig. 1A). Pro-
teins were expressed from insect cells using a baculovirus vector and purified using
protein G columns, resulting in isolation of a single protein (Fig. 1B). Those proteins
contained N-linked (but not O-linked) glycans, as shown by treatment with enzymes
specific for different glycosylation forms (Fig. 1C). As the proteins were produced in
insect cells, they would display high-mannose N-linked glycans and would not them-
selves be sialylated. Testing the specificities of the SGRPs in a solid-phase lectin binding
assay (spLBA) with either horse serum proteins (displaying 4-O-Ac Sias) or bovine
submaxilliary gland mucin (7,9-O-Ac Sias and 9-O-Ac Sias) showed the expected
binding specificities (Fig. 1D), and those were also confirmed by pretreating the Sia
substrates with the esterase-active form of the proteins before conducting the assay,
removing the binding substrate (Fig. 1D). The use of solutions at pH 6.5 during esterase
treatments prevents O-acetyl migration on the Sia glycerol side chain (56, 57), and
FIG 1 Expression and characterization of SGRPs. (A) Cartoon schematic of SGRPs. Nidovirus HE ectodo-
mains were expressed with a C-terminal tag of the human IgG Fc domain and a 6-His sequence. The
esterase active site Ser (denoted by red squares) was mutated to Ala to generate binding SGRPs. (B)
Expressed and purified SGRPs resolved on SDS-PAGE. (C) MHV-S HE-Fc treated with various glycosidases
and resolved on SDS-PAGE shows presence of N-linked (but not O-linked) glycosylation. (D) Solid-phase
lectin binding assays of SGRPs. Plates were coated with horse serum (MHV-S) or bovine submaxillary
mucin (PToV-P4, BCoV-Mebus) and probed with 2-fold dilutions of SGRPs (starting at 50 g/ml). Parallel
rows were treated during blocking with active-esterase forms of the proteins (Est).
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esterase controls performed alternatively at pH 7.5 confirmed previous findings of
BCoV-Mebus HE-Fc (but not PToV-P4 HE-Fc) binding to 7,9-O-Ac Sias present in bovine
mucin (58). We observed no binding of the SGRPs to nonmodified Sia substrates
(bovine fetuin, various animal serums) or nonsialylated glycoprotein substrates (results
not shown). Goat serum was used as a block of nonspecific binding of the anti-Fc
secondary antibody in all subsequent tissue staining experiments. The Sia of that serum
did not react with the probes on tissue slides or in testing performed by spLBA,
suggesting that the serum does not contain O-acetylated Sias (results not shown).
The binding specificity of the probes was tested on a glycan microarray containing
Neu4,5Ac2 (n  1), Neu5,9Ac2 (n  20), and Neu5Gc9Ac (n  1), along with their
equivalent but nonacetylated glycan forms (Fig. 2). Binding was ranked as relative
fluorescence units (RFU) (n  4, standard deviations [SD]). MHV-S HE-Fc bound very
specifically to Neu4,5Ac23Gal4GlcNAcR1 (R1propyl azide) as the only Neu4,5Ac2
glycan on the current array. Both PToV-P4 HE-Fc and BCoV-Mebus HE-Fc bind specifi-
cally to 9-O-Ac sialic acids. While PToV-P4 HE-Fc binds only to Neu5,9Ac2, BCoV-Mebus
HE-Fc binds to both Neu5,9Ac2 and Neu5Gc9Ac. Note that 9-O-acetylation is partially
lost on many spots because of instability. Thus, results on those spots are meaningful
only if binding is much better than that to the corresponding non-O-acetylated glycan
spot. Glycan microarray results correlated with our spLBA observations and largely
FIG 2 Glycan microarray screening of MHV-S HE-Fc, PToV-P4 HE-Fc, and BCoV-Mebus HE-Fc. The binding
is presented in heat map form. The heat map was generated according to a method previously described
(87). Binding was ranked and calculated as follows, where RFU represents relative fluorescence units:
(glycan RFU/maximum glycan RFU) * 100. Binding data represent results determined at 40 g/ml (n 
4, standard deviations [SD]).
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confirmed the Sia moiety specificity of the SGRPs. Glycan microarray results obtained
with our SGRPs consistently overlapped previous results reported for these nidovirus
HEs (14).
The distribution of O-acetyl Sias in tissue culture cells. The 4-O-Ac Sias were
found in cultured cells derived from horses (NBL-6), with between 10% and 30% of the
cells showing positive staining results by microscopy (Fig. 3) and flow cytometry (data
not shown). The 4-O-Ac Sias were not detected on the human (HEK-293, A549) or
canine (MDCK) cells examined (Fig. 3).
The 9-O-Ac and 7,9-O-Ac Sias were widely but variably displayed on cells from
different hosts, including several different human and animal cell lines (Fig. 3). The
specificity of the SGRPs for their modified Sia target on cells was confirmed by
9-O-acetylesterase-active treatment of MDCK cells prior to PToV HE-Fc probing (Fig. 3,
inset box). MDCK cells, which are frequently used for passage, amplification, and
titration of influenza viruses, display both 7,9-O-Ac and 9-O-Ac Sias on their plasma
membranes. Human cell lines (A549 and HEK-293) also synthesize 7,9-O-Ac and 9-O-Ac
Sias, but the majority was detected at intracellular sites, likely within the Golgi/
endoplasmic reticulum (ER) network based on their colocalization with GM130 as
detected by antibody staining (data not shown). The intracellular localization of 9-O-Ac
Sias in those human cells has been previously described (14). A horse cell line (NBL-6)
displayed both 7,9- and 9-O-Ac Sias in addition to the 4-O-Ac Sias, and those were
primarily detected on the cell surface.
The distribution of Sias in mouse respiratory tissues. To generally confirm the
binding of SGRPs and plant lectins to Sia forms in tissues, as well to determine their
distribution in a key laboratory animal, we surveyed the respiratory tissues of C57BL/6
mice by histochemistry (Fig. 4). Mice showed little 4-O-Ac Sia in the respiratory tract
tissues, with some signal seen in the lamina propria of the trachea and at pneumocytes
in the lung, but high levels were displayed in the tissues of the small and large
intestines (results not shown). Mice displayed 9-O-Ac (and 7,9-O-Ac) Sias in the trachea,
often in the submucosal glands but also at some tracheal epithelium, and in the lung
at pneumocytes of alveolar tissue. We also observed that the 9-O-Ac Sias were often
distributed on endothelial linings of vessels and on erythrocytes preserved in the tissue
sections. Lectin stains identified limited 2-6-linked Sias (SNA), with more-robust
staining for 2-3-linked Sias (MAH) being particularly abundant in the lungs (Fig. 4A).
FIG 3 Presence of O-acetyl modified Sias on a selection of cell lines from different hosts commonly used
for the growth and assay of influenza viruses. Cell lines of human (HEK-293, A549), canine (MDCK), and
equine (NBL-6) origin were screened with the SGRPs for the display of O-acetylated Sias. The display of
4-O-Ac Sias was isolated to horse origin NBL-6 cells, while all screened cells displayed 7,9-O-Ac and
9-O-Ac Sias. Human cell lines appeared to predominantly display 7,9-O-Ac and 9-O-Ac Sias intracellularly,
while MDCK cells displayed clearly on the membrane surface. Esterase treatment ablated probing for the
modified Sia form (MDCK for 9-O-Ac inset box).
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The same general Sia identification patterns were observed in frozen tissue sections as
in paraffin-embedded (PE) tissues. However, we observed staining variance in that
frozen sections had both lower signal in the trachea and higher levels in the lung of
9-O-Ac Sias than in formalin-fixed, paraffin-embedded (FFPE) tissue and also showed
some staining of the mucus that was still present on the slides (Fig. 4B).
The distribution of 4-O-acetyl Sias in mammalian influenza virus host respira-
tory tissues. The MHV-S HE-Fc SGRP showed a widespread display of 4-O-Ac Sias in the
tracheal and lung tissues of horses and guinea pigs (Fig. 5). In horses, the 4-O-Ac Sia
was displayed in the airway-exposed respiratory cells, including tracheal epithelia and
alveolar pneumocytes, and that therefore would likely be in contact with infecting
influenza viruses. Within the guinea pig respiratory tract, 4-O-Ac Sias were not seen at
the tracheal epithelium but rather were displayed in the submucosa at the endothelial
cells lining vessels. The lungs displayed significant 4-O-Ac Sia staining at alveolar
pneumocytes (and endothelia, again). We observed display of 4-O-Ac Sias in small
numbers of cells within ferret and dog tissues, but with little consistency or organiza-
FIG 4 (A) Staining (red) of FFPE mouse respiratory tissues for the distribution of O-acetylated modified
forms and Sia linkages. Controls with anti-human IgG Fc-specific antibody do not show background
staining. Trachea and lung of mice were highly enriched in 9-O-Ac (and 7,9-O-Ac) Sias, including at the
tracheal epithelium and lung pneumocytes. The 2-3-linked Sias are enriched in the mouse lung. (B)
Staining (red) of frozen mouse respiratory tissues for O-acetylated modified Sias shows detection results
similar to those seen with the FFPE tissue. Bars, 50 m.
FIG 5 Staining (red) of mammalian respiratory tissues for the distribution of the 4-O-Ac Sia, detected
with the MHV-S HE-Fc SGRP. Tracheal and lung sections were isolated from human, ferret, guinea pig, pig,
horse, and dog. 4-O-Ac Sias were predominately found in the respiratory tissues of horses and guinea
pigs, while trace signal was seen in ferret and dog tissues. Human and pig tissues appeared to contain
no 4-O-Ac Sias. Bars, 50 m.
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tion, and we did not observe any 4-O-Ac Sias in the examined respiratory tissues from
humans or pigs.
The distribution of 9- and 7,9-O-acetyl Sias in mammalian influenza virus host
respiratory tissues. We probed respiratory tissues using PToV-P4 HE-Fc to locate
9-O-Ac Sias (Fig. 6A) and BCoV-Mebus HE-Fc to locate 7,9-O-Ac Sias (Fig. 6B). The 7,9-
and 9-O-Ac Sias were present in tissues of all mammals screened here, but with distinct
tissue and cell display patterns. Human respiratory tissues displayed these modified Sias
in both the trachea and lung. Within the human trachea, 7,9- and 9-O-Ac Sias were
localized within submucosal glands, which are involved in excretion of respiratory
mucins. Within the human lung, they were displayed on alveolar pneumocytes, as well
as endothelia of vessels. The ferret lung displayed some 7,9- and 9-O-Ac Sias, while few
to none were detected in the examined guinea pig respiratory tissues. In the respiratory
tracts of pigs, horses, and dogs, 7,9- and 9-O-Ac Sias were displayed within the tracheal
epithelial cells. Overall, 7,9- and 9-O-Ac Sias appeared most abundant within the
respiratory tissues of humans in comparison to the other mammalian hosts surveyed.
The distribution of Sia linkages in mammalian influenza virus host respiratory
tissues. Staining of mammalian respiratory tissues with plant lectins (2-6-linked Sias
[SNA], 2-3-linked Sias [MAH]) for Sia linkages confirmed a significant presence of Sias
on the tissue sections (Fig. 7). Human respiratory tissues had abundant 2-6-linked Sias
(SNA) at the tracheal epithelium (Fig. 7A), while an increasing level of the 2-3-linked
forms (MAH) was seen in the lung (Fig. 7B). Ferrets displayed far more 2-6-linked Sias
in the lung and in the submucosal glands of the trachea, while levels of 2-3-linked Sias
appeared limited at vessels and in the lung alveolar tissue. Guinea pigs displayed both
Sia linkages, though 2-3-linked Sias were more likely to be detected at the tracheal
epithelium. Pigs displayed abundant 2-6-linked Sias at the tracheal epithelium, while
both linkage forms were found throughout the tissues. Horses showed fairly equivalent
levels of both Sia linkages in the respiratory tissues examined here. The tracheal
epithelium of dogs was enriched for 2-3-linked Sias, where staining of cilia was easily
observed.
The distribution of O-acetyl Sias in Pekin duck respiratory and gastrointestinal
tissues. Waterfowl of many types are the primary ecological hosts for influenza virus
FIG 6 (A) Staining (red) of mammalian respiratory tissues for the distribution of the 9-O-Ac Sia, detected
with the PToV-P4 HE-Fc SGRP. (B) Staining of respiratory tissues for the distribution of 7,9-O-Ac Sia,
detected with the BCoV-Mebus HE-Fc SGRP. Both Sia forms were identified in respiratory tissues of all
species examined, with variations in distribution and display. The 9-O-Ac and 7,9-O-Ac Sias generally
appeared to have similar patterns of distribution. Human tissues displayed 7,9- and 9-O-Ac Sias in the
tracheal submucosal glands and throughout the lung. These Sia forms were displayed at the tracheal
epithelia of pigs, horses, and dogs. Bars, 50 m.
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diversity in nature (59). Here we probed for O-acetylated Sias in respiratory (trachea,
lung) and gastrointestinal (small intestine, colon, cecum, cloaca) tissues of Pekin duck
(Anas platyrhynchos domesticus) and found the display of all O-acetyl Sias (Fig. 8A). By
probing with MHV-S HE-Fc, we showed that 4-O-Ac Sias were displayed within a few
epithelial cells of the trachea and alveolar pneumocytes of the lung but that none were
observed within the digestive tract tissues examined. 9-O-Ac Sias were detected on the
tracheal epithelia and within the lung pneumocytes in parallel to the 4-O-Ac, but we
did not see a similar respiratory display of the di-7,9-O-Ac Sia form. Within the cloaca,
we identified mono-9-O-Ac Sias within mucosal epithelia cell bodies lining the cloacal
opening. Within the intestines and colon, enteric ganglia displayed 7,9- and 9-O-Ac Sia
forms. An additional reported site of influenza replication, the pancreas, was screened
with no display observed (data not shown). Examination of Sia linkage by lectin staining
(SNA, MAH) confirmed the abundant presence of Sias in the tissue sections (Fig. 8B).
Respiratory tissues tended to display both 2-3-linked and 2-6-linked Sias, while
2-3-linked Sia forms predominated in gastrointestinal tissues at the epithelia. One
exception was the enriched display of 2-6-linked Sias within colonic crypts.
The distribution of O-acetyl Sias in embryonated chicken eggs. Embryonated
chicken eggs are used for the amplification of many influenza viruses for diagnostic and
experimental studies and for vaccine production, and they have been shown to display
primarily 2-3-linked Sias, resulting in rapid selection of human strains (33, 60). We
surveyed both embryonic tissue and a sampling of extraembryonic chorioallantoic
membranes (CAM). Staining performed with PToV-P4 HE-Fc showed that mono-9-O-Ac
Sia was present at high levels in the embryonic tissues and the extraembryonic
membranes (Fig. 9). However, BCoV-Mebus HE-Fc failed to stain those tissues for the
7,9-O-Ac form, and the 4-O-Ac Sia form was also not observed. A solid-phase assay
performed on allantoic fluid extracted from the eggs failed to identify any O-acetylated
Sias (data not shown), suggesting that the 9-O-Ac Sias are primarily expressed on the
cells of the embryos and the membranes. Staining with lectins for Sia linkage largely
confirmed the significant presence of 2-3-linked Sias (MAH) in both the embryo and
CAM, with only trace signals for 2-6-linked Sias (SNA).
FIG 7 (A) Staining (red) of mammalian respiratory tissues by SNA for analysis of the distribution of
2-6-linked Sias. Human tissues show abundant staining at the tracheal epithelium, similarly to pig
tissues. Ferret tissues display large amounts of 2-6-linked Sias in the submucosal glands and lung. (B)
Staining (red) of mammalian respiratory tissues by MAH for analysis of the distribution of 2-3-linked
Sias. These Sia linkages are displayed in the human lung alveolar tissue. They were found in all species
examined but were particularly enriched in dog tissue such as the trachea. Bars, 50 m.
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DISCUSSION
The overall goal of this study was to survey for the expression of the different
modified forms of Sia on the cells and tissues of animals that are natural or experi-
mental hosts of influenza viruses. We were able to confirm and extend prior work which
showed that 4-O-Ac, 9-O-Ac, and 7,9-O-Ac Sias are all widely but very variably distrib-
uted in the target tissues of animals that are hosts for influenza virus, on the cells of
chicken embryos, and on the cultured cells that are frequently used to propagate
influenza viruses in vitro. In general, 7,9-O-Ac and 9-O-Ac Sias were broadly present
across various species and their respective tissues and cell lines, while the 4-O-Ac Sias
were widely detected in the examined tissues from some animals (horses and guinea
pigs) but were not detected in the tissues from others (humans and pigs). We further
established a direct comparison of the distributions of Sia linkages, 2-6 and 2-3, in
these tissues using plant lectins SNA and MAH, respectively. Our findings in this study
are summarized in Table 1.
The cell lines examined are commonly used for influenza virus laboratory isolation
and growth studies, as are embryonated chicken eggs. Tissues sampled in the initial
screening included those that are commonly infected by influenza viruses as well as by
other respiratory viruses and bacteria. The respiratory tract tissues examined were
those from natural or laboratory animal hosts of influenza viruses, while the intestines
of ducks—which are among the natural reservoirs of those viruses—were also exam-
ined. The goal of this study was to form an initial picture of the distribution of the
modified Sias, some of which have been reported to interfere with receptor binding
and sialidase activity, to more clearly reveal their possible impact on viral replication
and transmission. The results provide initial data that can be used for the design of
studies for examining in detail the effects of the Sia modifications on influenza virus
infection and spread.
FIG 8 The distribution of Sias in the tissues of a Pekin duck, a major waterfowl reservoir of avian
influenza viruses. (A) Staining (red) of respiratory tissues with SGRPs for O-acetyl modified Sias. Both
4-O-Ac and 9-O-Ac Sias are displayed at tracheal epithelia and in lung alveolar tissue. Within the digestive
tissues, trace 7,9- and 9-O-Ac Sias are displayed in enteric ganglia of the intestines (Sm intestine, small
intestine), whereas epithelial cells of the cloaca display abundant mono-9-O-Ac Sias. (B) Staining (red) of
respiratory tissues for Sia linkage chemistry. Respiratory tissue displayed both Sia linkages, whereas
digestive tissues showed more predominant 2-3-linked Sias. Bars, 50 m.
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Display of 4-O-Ac Sias. The first conclusion was that 4-O-Ac Sias are displayed in
the respiratory tract tissues of guinea pigs and horses at high levels, as was likely based
on previous reports of the presence of modified Sias on eyrthrocytes and blood
proteins from those hosts (37, 61, 62). We observed some display of 4-O-Ac Sias in mice,
but the amount seen in respiratory tissues was not as great. Previous reports (and our
own unreported survey) showed that 4-O-Ac Sias in mice are highly tissue regulated
and most abundantly found in the gastrointestinal tract (14). That Sia form was also
identified in a very small number of cells within the duck, dog, and ferret respiratory
tissues screened but not in the tissues of humans and pigs, and it appears not to be
displayed on a variety of tissues examined in other studies in humans (14). We do not
yet know the gene(s) encoding the 4-O-acetyltransferase, so it is unclear whether the
trace display or absence of this modified Sia represents a genetic loss of the modifying
enzyme in some species or variably regulated expression. The high levels of display of
4-O-Ac Sias in horses and guinea pigs are of interest, as horses have been the natural
host of the H7N7 influenza virus, of two different H3N8 equine influenza viruses, and of
FIG 9 The distribution of Sias in tissues from 10-day postfertilization embryonated chicken eggs.
Staining (red) of embryonic tissues and extraembryonic chorioallantoic membranes (CAM) is shown. Only
mono-9-O-Ac Sias were detected in embryonic tissue and on CAM. There was significant staining for
2-3-linked Sias in the embryo and on membranes and limited presence of the 2-6-linked forms. Bars,
50 m.
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an unknown influenza strain that spread widely around the year 1872 (63), while guinea
pigs are naturally infected by and can transmit many strains of human influenza virus,
including both H1N1 and H3N2 lineages (64). The presence of 4-O-Ac Sias in the
respiratory tract therefore appears not to be a high barrier to at least some influenza
virus infections, and it is currently not known whether their presence impacts the
functions and evolution of HA and NA within the infecting influenza virus populations.
The guinea pig tissues examined here did not display the 4-O-Ac Sia on airway-exposed
tissues in the upper respiratory tract (trachea), so its role in laboratory infections
performed with human viruses is unknown. Horse and guinea pig sera have long been
known to be potent inhibitors of several H2 and H3 human influenza strains (35, 36, 65),
and resistance to those sera could be selected through mutations in the HA at residue
145 (H3) that ablate 4-O-Ac binding (61). The presence of various amounts of sialidase-
resistant Sias may therefore contribute to selection of influenza virus populations with
HA variants, while its display on some horse and guinea pig cells in culture may provide
an in vitro system suitable for the study of this modified Sia and its interactions with
influenza and other viruses. Little is known about the direct effects of 4-O-Ac Sia on
other microbes and pathogens, but their effects on sialidase (neuramindase) function
would likely alter susceptibility in many respiratory viral and bacterial pathogens
(66–68).
Display of 9-O-Ac and 7,9-O-Ac Sias. Both 9-O-Ac and 7,9-O-Ac Sias were widely
displayed within the respiratory tissues of the influenza virus hosts, although with
various locations and abundance levels. Previous studies performed using the influenza
C HEF protein or HE-Fc proteins from bovine coronavirus and porcine Torovirus as
probes for 7,9-O-Ac or 9-O-Ac Sias showed that they were widely displayed with
significant variations (8, 14). The finding that high levels of both 9-O-Ac and 7,9-O-Ac
Sias are found in the respiratory tracts of humans suggests that those may be a natural
ligand for the human influenza viruses, as does the finding of both those modified Sias
on MDCK cells and of the 9-O-Ac Sia in embyonated chicken chorioallantoic membrane
(CAM) cells. The 9-O-Ac Sias are the primary receptor for influenza C viruses, so their
expression in the respiratory tissues of humans and on chicken egg membranes allows
infection by that virus (69). However, the 9-O-Ac group may block binding of some
viruses, including strains of influenza A virus. The presence of 9-O-Ac Sias in the
submucosal glands of the human trachea suggests that they would be displayed in
mucus as part of the biophysical barrier to influenza virus contacting epithelial cell
receptors (70–73). The animal with the distribution of 9-O-Ac Sias that most closely
mirrored that of humans was the mouse. Their specific distribution in the respiratory
tracts of other mammalian species was more varied but included display in cells of the
tracheal epithelium of pigs, horses, and dogs. The influenza D virus group also utilizes
the 9-O-Ac Sia receptor, indicating that this Sia form is present in functional amounts
in the respiratory tracts of at least pigs, cows, and other ruminants (45), and 9-O-acetyl
forms are present at high levels in bovine submaxillary mucin (Fig. 1). In contrast, we
TABLE 1 Summary of results of survey of influenza virus hosts for presence of varied Sia
formsa
Host
4-O-Ac
(MHV)
9-O-Ac
(PToV)
7,9-O-Ac
(BCoV)
2-6
(SNA)
2-3
(MAH)
Mouse, BL6     
Human     
Ferret /    
Guinea pig  / /  
Pig     
Horse     
Dog /    
Duck, Pekin     
Chicken, egg    / 
a  , detected (relative qualitative abundance and distribution); /, trace detection (no clear
distribution or patterning); , not detected.
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were unable to detect 9-O-Ac Sias in the given respiratory tissues (trachea and lung) of
guinea pigs despite their ability to support influenza D virus infection (74). It is possible
that this receptor form is more abundant in the far upper respiratory tract, such as in
the nasal cavity. Display in duck tissues of both the respiratory tract and gastrointestinal
tract showed that such Sias would represent a Sia form encountered in the avian
influenza virus ecological life cycle. The recent identification of a 9-O-acetyltransferase
(CAS1 domain-containing protein 1 [CASD1]) will allow a closer examination of regu-
lated expression of the modifying enzyme and the impact on tissue-specific display of
7,9- and 9-O-Ac Sias (10). In addition, genetic manipulation of expression in cells will
allow testing of the functional effects of the modification.
Roles of modified Sia in controlling interactions with infectious pathogens.
Roles of modified Sia in altering the interactions of pathogens with hosts have been
known or suggested for many decades—and some strong evidence of effects on
influenza virus infection has been reported (31, 39, 61). Along with the well-known
differences in the linkages of the Sias, the modified Sias may further impact influenza
viruses at the population level, selecting for HA variants of Sia-binding avidity that may
also have additional effects on antigenicity in vivo (75).
An additional common modified Sia is N-glycolylneuraminic acid (Neu5Gc), which is
catalyzed from a Neu5Ac-CMP precursor by a CMP-N-acetylneuraminic acid hydroxylase
(CMAH) (76). This modified Sia is present at high levels in many natural influenza virus
hosts, including horses and pigs, as well as laboratory hosts such as mice and guinea
pigs (77). However, CMAH has been independently lost by mutation in several influenza
virus hosts, including humans and ferrets and likely in Western breeds of dogs (76, 78,
79). Neu5Gc may to be present but at low levels in tissues of avian lineages (80–82), but
as a CMAH homolog has not been found in birds, this expression may be due to
metabolic incorporation from dietary sources. Previous reports have shown that
Neu5Gc Sia presented on human cells allows influenza virus binding but may interfere
with productive virion entry and infection of some viruses (83).
In these studies, we examined the distribution of the O-acetylated Sias using the
new tools that have become available and did not specifically investigate the presence
of the nonmodified forms or of other multiply modified forms, if those were present.
That would require either the use of SGRPs that recognize only the nonmodified forms
or HPLC analysis of tissue lysates for the presence of modified Sias. Other probes
currently under development include CD22-Fc, which shows reduced or blocked Sia
binding when the 9-O-Ac modification is present (84, 85). Previous HPLC analysis has
allowed quantification of the ratios of the modified to unmodified Sias. In guinea pig
liver tissue, it was seen that Neu5Ac comprises 85% of Sias and that Neu5Gc and
Neu4,5Ac2 modified forms represent 5% and 10% of the remaining Sias, respectively
(24). This may represent an underestimation of the levels due to O-acetyl instability and
release during sample manipulation. Quantification by HPLC is an important part of Sia
analysis in clarifying the relative levels of abundance but fails to identify and visualize
the specific location of display of the modified Sia forms. In our future work, we will
seek to explicitly control the levels of the modified Sias by esterase treatments and by
modifying enzyme activities so that we can test their role in the infection and release
of influenza virus and other viruses.
Summary. The distribution of several types of modified Sias and their roles in
altering the interactions of pathogens with their hosts are still poorly understood
decades after the first reports of effects on virus infection and other functions. The use
of new tools such as those deployed here and other novel biochemical, genetic, and
experimental approaches will allow quantitative analysis of the expression of various
Sia moieties and of their effects on pathogens and host responses.
MATERIALS AND METHODS
Animal tissue samples. Animals tested in this study are listed in Table 1. Tissues collected at
necropsy were fixed in 10% phosphate-buffered formalin and were then trimmed and blocked for
paraffin embedding. Chicken eggs were harvested at 10 days postfertilization for embryonic tissue and
chorioallantoic membranes (CAM). The mice were of the C57BL/6 strain, and tissues were either frozen
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in an optimum cutting temperature (OCT) matrix or fixed in formalin as described for other animal
tissues. All postfixation processing was undertaken at the Animal Health Diagnostic Center at the Cornell
University College of Veterinary Medicine. Anonymous human tissue sections were obtained from the
University of Hong Kong Department of Pathology (per J. Nicholls) or United States Biomax, Inc.
(Derwood, MD). Human tissue samples are exempt from Institutional Review Board (IRB) review as they
originate from anonymous diagnostic specimens.
Expression and isolation of HE-Fc viral SGRPs. The sequences for expressing the ectodomains of
the hemagglutinin-esterase (HE) of three nidoviruses (MHV-S, PToV-P4, and BCoV-Mebus) (14, 86) were
synthesized by GenScript (Piscataway, NJ), with various degrees of insect codon optimization. To
generate probe molecules, esterase domains were inactivated by changing the active site Ser residue to
Ala by Q5 site-directed mutagenesis (New England Biolabs). The HE proteins were linked to the
baculovirus gp64 signal sequence peptide at their N termini, and the C terminus was fused to a linker
containing a thrombin cleavage sequence, the Fc domain of human IgG1, and a 6-His sequence.
Constructs were cloned into pFastBac-1 (Life Technologies, Inc.) and were then used to generate
recombinant bacmids in DH10Bac following the manufacturer’s protocol. Recombinant baculoviruses
were recovered by transfection of the bacmids into Sf-9 insect cells using Cellfectin II (Life Technologies,
Inc.). Viruses were then used to infect a suspension of High Five cells and supernatants harvested 2 to
3 days postinfection. Proteins were purified from the infected cell culture supernatants by binding to a
HiTrap protein G HP column (GE Healthcare Life Sciences, Piscataway, NJ) and eluted with 0.1 M citrate
(pH 3.0; pH neutralization to pH 7.8 with 1 M Tris, pH 9.0) using an Äkta fast protein liquid chromatog-
raphy (FPLC) system (GE Healthcare Life Sciences). The HE-Fc-containing fractions were dialyzed in
phosphate-buffered saline (PBS) and concentrated using 30-kDa Amicon Ultra-15 filters (EMD Millipore).
Purified protein was observed by SDS gel migration as well as anti-human IgG Fc probing by Western
blotting. Migration was retarded by the presence of glycosylation and confirmed by the use of various
glycosidases (EndoH, PNGase, and O-glycosidase; New England Biolabs). Protein concentrations were
determined from A280 readings, and proteins were stored at 80°C in aliquots or at 20°C in 50%
(vol/vol) glycerol.
Solid-phase SGRP binding assay. ELISA-grade 96-well plates were coated with Sia-containing
samples diluted in PBS (pH 6.5; 100 l/well) for 16 h at 4°C. Wells were washed between steps with
washing buffer (PBS [pH 6.5], 0.05% Tween 20). Wells were blocked in CarboFree (Vector Laboratories) for
1 h at 37°C. HE-Fc SGRPs were precomplexed (10:1 molar ratio) with horseradish peroxidase (HRP)-
conjugated goat anti-human Fc -specific antibody (Jackson ImmunoResearch, West Grove, PA) and were
applied to wells in 2-fold serial dilutions (starting at 50 g/l HE-Fc) in blocking buffer (50 l/well).
Bound HE-Fc was detected with ABTS [2,2=-azinobis(3-ethylbenzthiazolinesulfonic acid)] substrate
(Sigma). Optical densities were read at 405 nm. Samples depleted of specific O-Ac Sias were prepared by
exposure to the respective active esterase HE-Fc forms at 20 g/l during blocking.
Glycan microarray binding studies. Glycan microarrays were fabricated using epoxide-derivatized
slides as previously described (87). Printed glycan microarray slides were blocked by ethanolamine,
washed, and dried. Slides were then fitted in a multiwell microarray hybridization cassette (AHC4X8S;
ArrayIt, Sunnyvale, CA) to divide them into 8 subarrays. The subarrays were blocked with ovalbumin (1%
[wt/vol])–PBS (pH 7.4) for 1 h at room temperature (RT), with gentle shaking. Subsequently, the blocking
solution was removed and diluted protein samples with various concentrations were added to each
subarray. After incubation of the samples for 2 h at RT with gentle shaking, the slides were washed.
Diluted Cy3 AffiniPure goat anti-human IgG (HL) antibody (purchased from Jackson Immuno
Research Laboratories)-PBS was added to the subarrays, incubated for 1 h at RT, washed, and dried.
The microarray slides were scanned by the use of a Genepix 4000B microarray scanner (Axon
Instruments, Union City, CA). Data analysis was performed using Genepix Pro 7.0 analysis software
(Axon Instruments, Union City, CA).
Cell culture and staining of cultured cells. All mammalian cells were grown at 37°C with 5% CO2.
The cells tested included human HEK293T, human A549, canine MDCK, and equine NBL-6 cells. The cells
were grown in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum
(FBS). Insect cells (Sf-9 and High Five) were grown in Grace’s insect media supplemented with 10% FBS
at 23°C. Cells were probed for O-acetyl Sias by the use of virolectin probes and visualized by indirect
immunofluorescence. Cells grown on coverslips were fixed in 4% paraformaldehyde and blocked with
CarboFree (Vector Laboratories). Esterase-active treatment controls were performed by addition of active
HE-Fc (at 20 g/ml) during blocking at 37°C. Cells were permeabilized with Triton X-100. Cells were
probed with HE-Fc SGRPs (at 20 g/ml) in complex with Alexa Fluor 488-conjugated goat anti-human Fc
-specific antibody (10:1 molar ratio) for 45 min at RT. Colocalization to the secretory cis-Golgi network
was determined by utilization of an anti-GM130 antibody (Sigma). Coverslips were mounted and
visualized by fluorescence microscopy using a Nikon E3000 microscope.
Histochemical staining of tissues. Paraffin-embedded tissue sections on coated slides were dew-
axed in xylene and rehydrated. Frozen sections of mouse tissues were placed directly on slides and then
fixed with 10% buffered formalin. All subsequent washes were done with PBS–0.05% Tween 20 (PBS-T).
Sections were first blocked in CarboFree (10% normal goat serum for SGRP probing) for 1 h at 37°C.
Esterase treatment control slides were exposed to active esterase HE-Fc forms (20 g/l) during serum
blocking. Sections were further blocked with avidin/biotin (Vector Laboratories, Burlingame, CA) and
quenched of active peroxidase activity by the use of Bloxall (Vector Laboratories). Sections were probed
with HE-Fc SGRPs (at 20 g/ml) in complex with biotinylated goat anti-human Fc -specific antibody
(10:1 molar ratio) overnight at 4°C. Sections were probed with biotinylated plant lectins SNA (Vector
Laboratories) and MAH (MAA-II, Vector Laboratories) at 10 g/ml and 20 g/ml, respectively, for 3 h at
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RT. Sections were then exposed to ABC Vectastain strepavidin-HRP, followed by NovaRed HRP substrate
(Vector Laboratories). Sections were counterstained in hematoxylin, dehydrated, and embedded in
Cytoseal XYL.
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